Abstract
BLAU and Bender1 in 1960 first reported on the use of radioactive mercury (203Hg) chlormerodrin for the localization of brain tumors. Until recently evidence of the area of deposition of this material in Central-nervous-system lesions was not available. Recently, it has been demonstrated in primary brain tumors of the astrocytoma type that the radioactive mercury appears in or on the neoplastic cells.2 This paper will demonstrate that in a nonmalignant, intracranial meningioma and in a metastatic brain tumor the cellular localization of radioactive mercury is similar to that demonstrated in brain tumors of neuroglial origin. The methods and materials . . .
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
